Sargent Bickham Lagudis LLC Caribou Biosciences, Inc. Put Options Transaction History
Sargent Bickham Lagudis LLC
- $1.22 Billion
- Q4 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CRBU
# of Institutions
140Shares Held
52.6MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$19.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$12.6 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$11.6 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$11.4 Million0.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.34MShares$6.52 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $169M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...